ストックスクリーナーアプリを入手
22.58
0.96%
-0.22
アフターアワーズ：
22.56
-0.02
-0.09%
Catalyst Pharmaceuticals Inc (CPRX) 最新ニュース
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) - The Manila Times
Aug PreEarnings: Is Catalyst Pharmaceuticals Inc CN2 stock a contrarian opportunityJuly 2025 Retail & Weekly High Return Forecasts - moha.gov.vn
Why Catalyst Pharmaceutical (CPRX) is a top value stock for the long term - MSN
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? - Yahoo Finance
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? - The Motley Fool
Aug Closing: Why Catalyst Pharmaceuticals Inc stock remains resilient2025 Earnings Surprises & AI Powered Market Entry Strategies - moha.gov.vn
Catalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade - ts2.tech
Catalyst Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Exchange Traded Concepts LLC Grows Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Analysts see big upside in Catalyst Pharmaceuticals, Inc. (CPRX) - MSN
Voya Investment Management LLC Has $8.79 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Texas Permanent School Fund Corp Boosts Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Wedge Capital Management L L P NC Makes New $2.86 Million Investment in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途牛牛
First Week of February 2026 Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
Toth Financial Advisory Corp Has $42,000 Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Market Fear: Can Catalyst Pharmaceuticals Inc. stock outperform in 2025 bull marketPortfolio Return Summary & AI Powered Market Entry Ideas - Улправда
Market Fear: Will Catalyst Pharmaceuticals Inc CN2 stock sustain bullish trend into 2025Quarterly Profit Review & Consistent Growth Stock Picks - moha.gov.vn
Can Catalyst Pharmaceuticals Inc. stock outperform in 2025 bull marketJuly 2025 Price Swings & Daily Momentum Trading Reports - Улправда
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now - MSN
Will Catalyst Pharmaceuticals Inc. stock see insider buyingPortfolio Performance Report & Fast Exit Strategy with Risk Control - Улправда
Why Catalyst Pharmaceuticals Inc. stock remains resilientQuarterly Market Summary & Safe Entry Momentum Stock Tips - DonanımHaber
What hedge fund moves indicate for Catalyst Pharmaceuticals Inc. (CN2) stock2025 Technical Patterns & Growth Focused Entry Reports - DonanımHaber
Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 - Yahoo Finance
How A New US$200 Million Buyback At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story - Yahoo Finance
Molly Harper Takes Money Off The Table, Sells $621K In Catalyst Pharmaceuticals Stock - Benzinga
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Gains - Sahm
Catalyst Pharmaceuticals (NASDAQ:CPRX) Director Molly Harper Sells 26,746 Shares - MarketBeat
Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025 - ts2.tech
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Castleark Management LLC Sells 123,370 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Does Catalyst Pharmaceuticals Still Offer Value After Its 559.8% Five Year Surge in 2025? - Sahm
Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi‑Year Share Price Surge? - Yahoo Finance
Globeflex Capital L P Increases Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) - Insider Monkey
JPMorgan Chase & Co. Buys 81,188 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Cresset Asset Management LLC Has $1.90 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Transcript : Catalyst Pharmaceuticals, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 12 - marketscreener.com
How Investors Are Reacting To Catalyst Pharmaceuticals (CPRX) Upgraded 2025 Sales Outlook And Easing Short Interest - Sahm
Arrowstreet Capital Limited Partnership Purchases 188,594 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? - sharewise.com
Kennedy Capital Management LLC Cuts Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceutical (CPRX) Recently Broke Out Above the 20-Day Moving Average - Finviz
Should I hold or sell Catalyst Pharmaceuticals Inc. stock in 2025Earnings Recap Report & Fast Moving Stock Watchlists - Newser
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? - Yahoo Finance
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) (CPRX) - Seeking Alpha
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):